Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury - PubMed (original) (raw)

Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury

Xiao-Tian Wang et al. Cell Signal. 2007 Sep.

Abstract

Increasing evidence suggests that the Bcl-2 family proteins play pivotal roles in regulation of the mitochondria cell-death pathway on transient cerebral ischemia. Bad, a BH3-only proapoptotic Bcl-2 family protein, has been shown to be phosphorylated extensively on serine by kinds of kinases. However, the exact mechanisms of the upstream kinases in regulation of Bad signaling pathway remain unknown. Here, we reported that Bad could be phosphorylated not only by Akt1 but also by JNK1/2 after transient global ischemia in rat hippocampal CA1 region. Our data demonstrated that Akt1 mediated the phosphorylation of Bad at serine 136, which increased the interaction of serine 136-phosphorylated Bad with 14-3-3 proteins and prevented the dimerization of Bad with Bcl-Xl, inhibited the release of cytochrome c to the cytosol and the death effector caspase-3 activation, leading to the survival of neuron. In contrast, JNK1/2 induced the phosphorylation of Bad at a novel site of serine 128 after brain ischemia/reperfusion, which inhibited the interaction of PI3K/Akt-induced serine 136-phosphorylated Bad with 14-3-3 proteins, thereby promoted the apoptotic effect of Bad. In addition, activated Akt1 inhibited the activation of Bad(S128) through downregulating JNK1/2 activation, thus inhibiting JNK-mediated Bad apoptosis pathway. Furthermore, the fate of cell to survive or to die was determined by a balance between prosurvival and proapoptotic signals. Taken together, our studies reveal that Bad phosphorylation at two distinct sites induced by Akt1 and JNK1/2 have opposing effects on ischemic brain injury, and present the possibility of Bad as a potential therapeutic target for stroke treatment.

PubMed Disclaimer

Cited by

c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury.
Shvedova M, Anfinogenova Y, Atochina-Vasserman EN, Schepetkin IA, Atochin DN. Shvedova M, et al. Front Pharmacol. 2018 Jul 5;9:715. doi: 10.3389/fphar.2018.00715. eCollection 2018. Front Pharmacol. 2018. PMID: 30026697 Free PMC article. Review.
Super-resolution microscopy reveals that Na+/K+-ATPase signaling protects against glucose-induced apoptosis by deactivating Bad.
Bernhem K, Fontana JM, Svensson D, Zhang L, Nilsson LM, Scott L, Blom H, Brismar H, Aperia A. Bernhem K, et al. Cell Death Dis. 2021 Jul 27;12(8):739. doi: 10.1038/s41419-021-04025-8. Cell Death Dis. 2021. PMID: 34315852 Free PMC article.
Effect of silencing of high mobility group A2 gene on gastric cancer MKN-45 cells.
Wei CH, Wei LX, Lai MY, Chen JZ, Mo XJ. Wei CH, et al. World J Gastroenterol. 2013 Feb 28;19(8):1239-46. doi: 10.3748/wjg.v19.i8.1239. World J Gastroenterol. 2013. PMID: 23482887 Free PMC article.
Beta-catenin promotes survival of renal epithelial cells by inhibiting Bax.
Wang Z, Havasi A, Gall JM, Mao H, Schwartz JH, Borkan SC. Wang Z, et al. J Am Soc Nephrol. 2009 Sep;20(9):1919-28. doi: 10.1681/ASN.2009030253. Epub 2009 Aug 20. J Am Soc Nephrol. 2009. PMID: 19696224 Free PMC article.
Ras family small GTPase-mediated neuroprotective signaling in stroke.
Shi GX, Andres DA, Cai W. Shi GX, et al. Cent Nerv Syst Agents Med Chem. 2011 Jun 1;11(2):114-37. doi: 10.2174/187152411796011349. Cent Nerv Syst Agents Med Chem. 2011. PMID: 21521171 Free PMC article. Review.

Opposing effects of Bad phosphorylation at two distinct sites by Akt1 and JNK1/2 on ischemic brain injury - PubMed (original) (raw)